Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia.

× No keyword cloud information.

15 in total

1. p53 codon 72 genotype affects apoptosis by cytosine arabinoside in blood leukocytes.

Authors: Massimiliano Bonafè; Stefano Salvioli; Cristiana Barbi; Michele Mishto; Chiara Trapassi; Claudia Gemelli; Gianluca Storci; Fabiola Olivieri; Daniela Monti; Claudio Franceschi
Journal: Biochem Biophys Res Commun Date: 2002-12-13 Impact factor: 3.575

Review 2. Acute Myeloid Leukemia.

Authors: Hartmut Döhner; Daniel J Weisdorf; Clara D Bloomfield
Journal: N Engl J Med Date: 2015-09-17 Impact factor: 91.245

3. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression.

Authors: C Venot; M Maratrat; C Dureuil; E Conseiller; L Bracco; L Debussche
Journal: EMBO J Date: 1998-08-17 Impact factor: 11.598

4. Prognostic importance of CD56 expression in intermediate risk acute myeloid leukaemia.

Authors: Juan L Coelho-Silva; Luany E Carvalho; Mayara M Oliveira; Pedro L Franca-Neto; Adryanna T Andrade; Aleide S Lima; Matheus F Bezerra; Marinus M Lima; Maria A Neves; Julia M Fonseca; Maria C Barros-Correia; Cintia G Machado; Marcos A Bezerra; Daniel M Matos; Antonio R Lucena-Araujo
Journal: Br J Haematol Date: 2016-02-23 Impact factor: 6.998

5. TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome.

Authors: Frank G Rücker; Richard F Schlenk; Lars Bullinger; Sabine Kayser; Veronica Teleanu; Helena Kett; Marianne Habdank; Carla-Maria Kugler; Karlheinz Holzmann; Verena I Gaidzik; Peter Paschka; Gerhard Held; Marie von Lilienfeld-Toal; Michael Lübbert; Stefan Fröhling; Thorsten Zenz; Jürgen Krauter; Brigitte Schlegelberger; Arnold Ganser; Peter Lichter; Konstanze Döhner; Hartmut Döhner
Journal: Blood Date: 2011-12-20 Impact factor: 22.113

Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia.

1. p53 codon 72 genotype affects apoptosis by cytosine arabinoside in blood leukocytes.

Review 2. Acute Myeloid Leukemia.

3. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression.

4. Prognostic importance of CD56 expression in intermediate risk acute myeloid leukaemia.

5. TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome.

6. p53 polymorphic variants at codon 72 exert different effects on cell cycle progression.

7. Trp53-dependent DNA-repair is affected by the codon 72 polymorphism.

8. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential.

9. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.

10. Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies.

1. The TP53 Pro72Arg SNP in de novo acute myeloid leukemia.